Hindering HIV

By Jef Akst Hindering HIV Courtesy of Devon Gregory and Marc Johnson The paper: S.J.D. Neil et al., “Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu,” Nature 451:425–30, 2008. (Cited in 96 papers) The finding: To be released from some cells, HIV-1 requires an accessory protein called Vpu, suggesting that these cells carry a host factor that inhibits the release of virions

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:

S.J.D. Neil et al., “Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu,” Nature 451:425–30, 2008. (Cited in 96 papers)

The finding:

To be released from some cells, HIV-1 requires an accessory protein called Vpu, suggesting that these cells carry a host factor that inhibits the release of virions. To identify this mysterious antiviral molecule, virologist Paul Bieniasz of the Aaron Diamond AIDS Research Center at The Rockefeller University and his colleagues compared mRNA expression between cells in which HIV-1 needs Vpu and cells in which HIV-1 could be released without Vpu, to find the genes associated with the Vpu requirement. They found CD317.

The mechanism:

Bieniasz and his team nicknamed CD317 “tetherin” because of its suspected mode of action: forming a physical tether between the budding virus particle and the infected cell, which “prevents virions from infecting [distant] cells,” Bieniasz says. Last October, he showed that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo